Back to ROSG Stock Lookup

ROSG – Press Releases

Apr 4, 2014 08:15 AM Rosetta Genomics to Receive U.S. Patent for Cancer Origin Assay
Apr 2, 2014 09:08 AM Rosetta Genomics and Marina Biotech Establish Strategic Alliance to Jointly Develop microRNA-Based Diagnostics and Therapeutics for Rare Diseases
Mar 31, 2014 06:05 PM Rosetta Genomics Reports 2013 Financial Results
Mar 25, 2014 02:50 PM Rosetta Genomics to Host Business Update Conference Call on April 1, 2014
Mar 24, 2014 09:15 AM Rosetta Genomics Enters Collaboration With Clalit Health Services' Rabin Medical Center for microRNA-Based Assay for Chronic Allograft Dysfunction Following Kidney Transplantation
Mar 21, 2014 12:15 PM Rosetta Genomics' Cancer Origin Test Highlighted at Landmark CUP Foundation Seminar 2014
Mar 12, 2014 08:15 AM Rosetta Genomics Provides Product Pipeline Update
Mar 3, 2014 09:15 AM Rosetta Genomics Announces Publication of Data Correlating miR-150 to Atrial Fibrillation in Patients With Chronic Systolic Heart Failure
Feb 26, 2014 08:45 AM Rosetta Genomics to Receive Important U.S. Patent for Oncology Therapeutic
Feb 18, 2014 08:45 AM Rosetta Genomics Executes Agreement With MultiPlan
Feb 18, 2014 08:25 AM Rosetta Genomics Appoints Kevin Watson as Director, Reimbursement-Managed Care
Jan 21, 2014 08:30 AM Rosetta Cancer Origin Test Now Covered by Highmark Health Services, the Fourth Largest U.S. Blue Cross and Blue Shield-Affiliated Company

Back to ROSG Stock Lookup